These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809 [TBL] [Abstract][Full Text] [Related]
3. Nestin and other putative cancer stem cell markers in pancreatic cancer. Matsuda Y; Kure S; Ishiwata T Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289 [TBL] [Abstract][Full Text] [Related]
4. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers. Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis. Li X; Zhao H; Gu J; Zheng L Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393 [TBL] [Abstract][Full Text] [Related]
6. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma. Skoda J; Hermanova M; Loja T; Nemec P; Neradil J; Karasek P; Veselska R PLoS One; 2016; 11(7):e0159255. PubMed ID: 27414409 [TBL] [Abstract][Full Text] [Related]
7. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091 [TBL] [Abstract][Full Text] [Related]
8. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. Matsuda Y; Yoshimura H; Ueda J; Naito Z; Korc M; Ishiwata T Am J Pathol; 2014 Mar; 184(3):674-85. PubMed ID: 24412093 [TBL] [Abstract][Full Text] [Related]
9. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655 [TBL] [Abstract][Full Text] [Related]
10. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912 [TBL] [Abstract][Full Text] [Related]
11. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer. Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells. Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497 [TBL] [Abstract][Full Text] [Related]
13. Pen2/ErbB4 signaling regulates stemness of pancreatic ductal carcinoma. Zhu Z; Ding D; Hu H; He T Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167316. PubMed ID: 38901650 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Welsch T; Keleg S; Bergmann F; Degrate L; Bauer S; Schmidt J Clin Exp Metastasis; 2009; 26(7):701-11. PubMed ID: 19488831 [TBL] [Abstract][Full Text] [Related]
15. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma. Song W; Li Q; Wang L; Huang W; Wang L Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418 [TBL] [Abstract][Full Text] [Related]
16. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma. Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841 [No Abstract] [Full Text] [Related]
17. Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Cheng X; Kim JY; Ghafoory S; Duvaci T; Rafiee R; Theobald J; Alborzinia H; Holenya P; Fredebohm J; Merz KH; Mehrabi A; Hafezi M; Saffari A; Eisenbrand G; Hoheisel JD; Wölfl S Mol Oncol; 2016 Jun; 10(6):806-24. PubMed ID: 26887594 [TBL] [Abstract][Full Text] [Related]
18. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma. Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma. Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes. Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]